Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.37 |
| ▸ | MAPT | P10636 | 6/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 4/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | RAB9A | P51151 | 3/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | HPGD | P15428 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 3/20 | 0.34 |
| ▸ | CASP3 | P42574 | 2/20 | 0.34 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.34 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.34 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | CASP6 | P55212 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL217121 | 0.82 | ALDH1A1 (0.34) | KDM4EMAPTALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL4921196 | 0.82 | MEN1 (0.38) | KDM4EMAPTALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL7633764 | 0.80 | METAP1 (0.47) | ALDH1A1MAOACYP1A2HTR2CCYP3A4 | |
| SCHEMBL328868 | 0.80 | MAPT (0.35) | KDM4EMAPTALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL4916055 | 0.80 | NPC1 (0.35) | KDM4EMAPTALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL4915519 | 0.79 | LTA4H (0.35) | KDM4EMAPTALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL4723228 | 0.78 | PTGS2 (0.48) | KDM4EMAPTALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL2478927 | 0.77 | RAB9A (0.40) | KDM4EMAPTALDH1A1SMN1; SMN2RAB9A | |
| SCHEMBL216980 | 0.77 | ALDH1A1 (0.40) | KDM4EMAPTALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL1029280 | 0.74 | ALDH1A1 (0.38) | KDM4EMAPTALDH1A1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9296738-B2 | Organic electroluminescent material, the process for preparing the same and OLED device using the same | EVERDISPLAY OPTRONICS (SHANGHAI) LIMITED (CN) | 2016-03-29 | — | — | US | claimed |
| US-20150203485-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, THE PROCESS FOR PREPARING THE SAME AND OLED DEVICE USING THE SAME | EVERDISPLAY OPTRONICS (SHANGHAI) CO., LTD. (CN) | 2015-07-23 | — | — | US | claimed |
| EP-0577581-B1 | Method for controlling the melting points and molecular weights of syndiotactic polyolefins using metallocene catalyst systems | FINA TECHNOLOGY (US) | 2000-07-05 | — | — | EP | claimed |
| EP-3438102-B1 | GLYCIDYL ESTER COMPOUND PREPARATION METHOD | KOLON INC (KR) | 2021-07-07 | — | — | EP | disclosed |
| US-10954206-B2 | Glycidyl ester compound preparation method | KOLON INDUSTRIES, INC. (KR) | 2021-03-23 | — | — | US | disclosed |
| US-20200299247-A1 | GLYCIDYL ESTER COMPOUND PREPARATION METHOD | KOLON INDUSTRIES, INC. (KR) | 2020-09-24 | — | — | US | disclosed |
| EP-3495424-B1 | COMPOSITION FOR PHOTO-ALIGNMENT LAYER AND PHOTO-ALIGNMENT LAYER | LG CHEMICAL LTD (KR) | 2020-09-09 | — | — | EP | disclosed |
| CN-107109231-B | Vertically oriented layer comprising cyclic olefin (co) polymer | 株式会社LG化学 | 2020-03-06 | — | — | CN | disclosed |
| US-10453420-B2 | Base film, laminated structure including the same, and display device | LG CHEM, LTD. (KR) | 2019-10-22 | — | — | US | disclosed |
| EP-3495424-A1 | COMPOSITION FOR PHOTO-ALIGNMENT LAYER AND PHOTO-ALIGNMENT LAYER | LG Chem, Ltd. (KR) | 2019-06-12 | — | — | EP | disclosed |
| EP-3196236-B1 | VERTICAL ALIGNMENT FILM COMPRISING (CO)POLYMER OF CYCLIC OLEFIN COMPOUND | LG CHEMICAL LTD (KR) | 2019-04-10 | — | — | EP | disclosed |
| US-20080200475-A1 | 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors | PFIZER INC. | 2008-08-21 | — | — | US | disclosed |
| US-20070293640-A1 | Multiple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. | 2007-12-20 | — | — | US | disclosed |
| EP-1866317-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | Pharmacia & Upjohn Company LLC (US) | 2007-12-19 | — | — | EP | disclosed |
| US-7294681-B2 | Mutliple catalyst system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-11-13 | — | — | US | disclosed |
| US-7223822-B2 | Multiple catalyst and reactor system for olefin polymerization and polymers produced therefrom | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-05-29 | — | — | US | disclosed |
| WO-2006103555-A1 | 4-PIPERAZINOTHIENO [2, 3-D] PYRIMIDINE COMPOUNDS AS PLATELET AGGREGATION INHIBITORS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2006-10-05 | — | — | WO | disclosed |
| EP-1473323-A1 | Polyethylene composition and process for producing same | Tosoh Corporation (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-20040214953-A1 | Polyethylene composition and process for producing same | TOSOH CORPORATION | 2004-10-28 | — | — | US | disclosed |
| US-5688735-A | COORDINATION CATALYST | FINA TECHNOLOGY, INC. (US) | 1997-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150203485-A1 | ORGANIC ELECTROLUMINESCENT MATERIAL, THE PROCESS FOR PREPARING THE SAME AND OLED DEVICE USING THE SAME | OCIAD1, OCIAD2, OR10J3 | KDM4E 1407/4885MAPT 3498/4885ALDH1A1 897/4885 |
| US-20200299247-A1 | GLYCIDYL ESTER COMPOUND PREPARATION METHOD | AGER, CYP4A11, GK | KDM4E 645/4885MAPT 2759/4885ALDH1A1 2757/4885 |
| US-10954206-B2 | Glycidyl ester compound preparation method | AGER, CYP4A11, GK | KDM4E 645/4885MAPT 2759/4885ALDH1A1 2757/4885 |
| US-20080200475-A1 | 4-Piperazinothieno[2,3-D] Pyrimidine Compounds As Platelet Aggregation Inhibitors | PF4, TBXA2R, P2RY4 | KDM4E 2775/4885MAPT 4568/4885ALDH1A1 849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.